Citigroup’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$163K Sell
11,738
-12,480
-52% -$171K ﹤0.01% 4084
2025
Q4
$334K Buy
24,218
+18,703
+339% +$440K ﹤0.01% 3764
2025
Q3
$135K Sell
5,515
-28,175
-84% -$686K ﹤0.01% 4153
2025
Q2
$778K Sell
33,690
-42,592
-56% -$1.12M ﹤0.01% 3335
2025
Q1
$2.06M Sell
76,282
-3,264
-4% -$123K ﹤0.01% 2678
2024
Q4
$4.26M Buy
79,546
+58,070
+270% +$3.07M ﹤0.01% 2132
2024
Q3
$976K Buy
21,476
+5,881
+38% +$256K ﹤0.01% 3281
2024
Q2
$653K Sell
15,595
-25,977
-62% -$1.22M ﹤0.01% 3218
2024
Q1
$1.57M Buy
41,572
+37,745
+986% +$822K ﹤0.01% 2641
2023
Q4
$41.1K Buy
3,827
+3,337
+681% +$28.9K ﹤0.01% 4621
2023
Q3
$4.94K Sell
490
-5,297
-92% -$61.1K ﹤0.01% 4724
2023
Q2
$68.7K Buy
5,787
+5,228
+935% +$69.9K ﹤0.01% 4450
2023
Q1
$6.76K Buy
559
+162
+41% +$2.7K ﹤0.01% 4867
2022
Q4
$5.23K Sell
397
-588
-60% -$8.61K ﹤0.01% 5025
2022
Q3
$13K Sell
985
-1,166
-54% -$15.6K ﹤0.01% 4899
2022
Q2
$26K Buy
2,151
+301
+16% +$3.56K ﹤0.01% 4857
2022
Q1
$27K Sell
1,850
-2,934
-61% -$48K ﹤0.01% 5001
2021
Q4
$94K Buy
4,784
+3,029
+173% +$63.5K ﹤0.01% 4763
2021
Q3
$38K Sell
1,755
-84,940
-98% -$2.44M ﹤0.01% 4892
2021
Q2
$2.16M Buy
+86,695
New +$1.93M ﹤0.01% 2606

Other funds holding JANX